Meropenem 1 g Injection bulk supplier for pharma manufacturers

Meropenem 1 g Injection 500 mg, 1 g, 2 g per vial Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV)

Available Strengths: 500 mg, 1 g, 2 g per vial

Reference Brands: Merrem (US & EU)

Meropenem inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, causing bacteria to lyses and die. It offers broad-spectrum activity against resistant gram-negative and gram-positive bacteria, including Pseudomonas. Benefits include rapid bactericidal effect, good tissue penetration, and suitability for severe, life-threatening infections in hospital settings.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Meropenem 1 g Injection? List it or send an offer →

Product Description:

Meropenem IV is approved in the EU and US for severe bacterial infections, including pneumonia, meningitis, and intra-abdominal infections. In the EU, brands like Merrem are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on extensive clinical data, with generic options available. Both regions require detailed dossiers, including clinical trial results, quality control, and pharmacovigilance plans for approval and safety monitoring. Due to its critical role in fighting resistant infections, strict prescribing controls and safety guidelines are enforced. We support seamless market access while ensuring adherence to European and US standards.

Meropenem 1 g Injection — third party manufacturing & bulk supply

Meropenem 1 g Injection 500 mg, 1 g, 2 g per vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Meropenem 1 g Injection is supplied as Intravenous (IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Meropenem 1 g Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Meropenem 1 g Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Meropenem is used to treat serious bacterial infections such as complicated intra-abdominal infections, meningitis, hospital-acquired pneumonia, and complicated skin and soft tissue infections. It is commonly administered in hospitals for infections caused by susceptible bacteria.

Meropenem is made from the active pharmaceutical ingredient meropenem trihydrate, a broad-spectrum carbapenem antibiotic that works by inhibiting bacterial cell wall synthesis and stopping the growth of bacteria.

Common trade names include Merrem and Merosan.

The originator brand Merrem was developed and marketed by AstraZeneca. Generic versions including Merosan and other brands are manufactured by various pharmaceutical companies globally.

The generic name is meropenem trihydrate.

Brand names include Merrem and Merosan.

Meropenem injections are manufactured in several countries including the United States, European countries, India, and Latin American regions in pharmaceutical facilities that follow regulatory standards such as US FDA, EMA, and other national authorities.